Cas no 40733-26-4 (3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine)
3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine Chemical and Physical Properties
Names and Identifiers
-
- 3',5'-bis-o-(t-butyldimethylsilyl)thymidine
- 3’, 5’-BIS-O-(T-BUTYLDIMETHYLSILYL)THYMIDINE
- 1-[γ-(p-Aminophenyl)propoxy]-2-diethylamino-ethan
- 1-{(1S)-2-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-1-[3-(trifluoromethoxy) phenyl]ethyl}cyclohexanol
- 1-{(2R,4S,5R)-4-(tert-butyldimethylsilyloxy)-5-[(tert-butyldimethylsilyloxy)methyl]tetrahydrofuran-2-yl}-5-methylpyrimidine-2,4(1H,3H)-dione
- 1--2-diethylamino-ethan
- 3',5'-
- 3',5'-bis(O-tert-butyldimethylsilyl)-5-methyl-2'-deoxyuridine
- 4-[3-(2-diethylaminoethyloxy)propyl]aniline
- AC1L1P55
- SCHEMBL1514947
- 3'',5''-Bis-O-(tert-Butyldimethylsilyl)thymidine
- D86094
- 1-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
- 1-((2R,4S,5R)-4-(tert-butyldimethylsilyloxy)-5-((tert-butyldimethylsilyloxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
- 40733-26-4
- MFCD01631042
- C22H42N2O5Si2
- 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine
-
- Inchi: 1S/C22H42N2O5Si2/c1-15-13-24(20(26)23-19(15)25)18-12-16(29-31(10,11)22(5,6)7)17(28-18)14-27-30(8,9)21(2,3)4/h13,16-18H,12,14H2,1-11H3,(H,23,25,26)/t16-,17+,18+/m0/s1
- InChI Key: DDLOCFSZSYGOPG-RCCFBDPRSA-N
- SMILES: [Si](C)(C)(C(C)(C)C)O[C@H]1C[C@H](N2C(NC(C(C)=C2)=O)=O)O[C@@H]1CO[Si](C)(C)C(C)(C)C
Computed Properties
- Exact Mass: 470.26300
- Monoisotopic Mass: 470.26322551g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 31
- Rotatable Bond Count: 8
- Complexity: 737
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 3
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 77.1?2
Experimental Properties
- PSA: 82.55000
- LogP: 4.54470
3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | B585380-50mg |
3',5'-Bis-O-[(1,1-dimethylethyl)dimethylsilyl]thymidine |
40733-26-4 | 50mg |
$ 655.00 | 2023-04-18 | ||
| TRC | B585380-100mg |
3',5'-Bis-O-[(1,1-dimethylethyl)dimethylsilyl]thymidine |
40733-26-4 | 100mg |
$ 1275.00 | 2023-04-18 | ||
| TRC | B585380-250mg |
3',5'-Bis-O-[(1,1-dimethylethyl)dimethylsilyl]thymidine |
40733-26-4 | 250mg |
$ 2888.00 | 2023-04-18 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | R939951-100mg |
1-((2R,4S,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione |
40733-26-4 | 95% | 100mg |
¥1,404.00 | 2022-08-31 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | R939951-250mg |
1-((2R,4S,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione |
40733-26-4 | 95% | 250mg |
¥2,340.00 | 2022-08-31 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | R939951-1g |
1-((2R,4S,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione |
40733-26-4 | 95% | 1g |
¥4,680.00 | 2022-08-31 | |
| abcr | AB591019-100mg |
3',5'-Bis-O-(t-butyldimethylsilyl)thymidine; . |
40733-26-4 | 100mg |
€737.90 | 2024-07-20 | ||
| abcr | AB591019-250mg |
3',5'-Bis-O-(t-butyldimethylsilyl)thymidine; . |
40733-26-4 | 250mg |
€1151.10 | 2024-07-20 | ||
| abcr | AB591019-500mg |
3',5'-Bis-O-(t-butyldimethylsilyl)thymidine; . |
40733-26-4 | 500mg |
€1593.10 | 2024-07-20 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | SY334416-1g |
3’,5’-O-Di(tert-butyldimethylsilyl)thymidine |
40733-26-4 | ≥95% | 1g |
¥9900.00 | 2025-04-14 |
3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine Suppliers
3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine Related Literature
-
Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
Additional information on 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine
Recent Advances in the Study of 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine (CAS: 40733-26-4)
The compound 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine (CAS: 40733-26-4) has garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique properties and potential applications in nucleic acid research and drug development. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and therapeutic potential.
Recent studies have highlighted the role of 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine as a key intermediate in the synthesis of modified nucleosides. Its silyl-protected structure offers enhanced stability and selectivity, making it a valuable tool for the development of oligonucleotide-based therapeutics. Researchers have successfully utilized this compound in the synthesis of antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), which are pivotal in gene silencing and targeted therapy.
One of the most notable advancements is the application of 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine in the development of prodrugs. A study published in the Journal of Medicinal Chemistry demonstrated that this compound can be used to improve the bioavailability and cellular uptake of nucleoside analogs, which are commonly used in antiviral and anticancer therapies. The silyl-protecting groups facilitate controlled release of the active drug, thereby enhancing therapeutic efficacy while minimizing off-target effects.
In addition to its therapeutic applications, 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine has been employed in mechanistic studies of DNA repair and replication. Its structural similarity to natural thymidine allows it to serve as a probe for investigating enzymatic processes involved in nucleic acid metabolism. Recent findings suggest that this compound can inhibit the activity of certain DNA polymerases, providing insights into the design of novel polymerase inhibitors for cancer treatment.
Despite these promising developments, challenges remain in the large-scale synthesis and purification of 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine. Researchers are actively exploring more efficient synthetic routes and purification techniques to address these issues. Advances in flow chemistry and automated synthesis platforms are expected to play a crucial role in overcoming these hurdles.
In conclusion, 3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine (CAS: 40733-26-4) represents a versatile and valuable compound in the field of chemical biology and medicinal chemistry. Its applications in oligonucleotide synthesis, prodrug development, and mechanistic studies underscore its potential to drive innovation in drug discovery and therapeutic interventions. Future research should focus on optimizing its synthesis and expanding its utility in emerging areas such as CRISPR-based gene editing and mRNA therapeutics.
40733-26-4 (3',5'-Bis-O-(1,1-dimethylethyl)dimethylsilylthymidine) Related Products
- 119794-52-4(5'-O-[(1,1-Dimethylethyl)dimethylsilyl]-5-methyluridine)
- 922508-26-7(2'-TBDMS-5-Me-rU)
- 139925-83-0(Thymidine, 3'-O-[(1,1-dimethylethyl)dimethylsilyl]-4'-methyl-)
- 376394-39-7(Thymidine, 5'-O-[(1,1-dimethylethyl)dimethylsilyl]-3'-O-2-propenyl-)
- 921199-55-5(2,4(1H,3H)-Pyrimidinedione, 1-[(5S)-5-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]tetrahydro-2-furanyl]-5-methyl-)
- 40733-28-6(5'-O-TBDMS-dT)
- 139925-98-7(Thymidine,5'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-4'-(hydroxymethyl)-)
- 130128-70-0(Thymidine, 5'-amino-5'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-)
- 139887-99-3(Thymidine, 3'-O-[(1,1-dimethylethyl)dimethylsilyl]-4'-(hydroxymethyl)-)
- 40733-27-5(3'-O-(TBDMS)Thymidine)